Global Follow-on Biologics Market By Product Type (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins) And By End-Users/Application (Oncology, Blood Disorders) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global Follow-on Biologics Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Follow-on Biologics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. Follow-on Biologics Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of Follow-on Biologics from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into Follow-on Biologics Market include: Sandoz Pfizer Teva Pahrmaceutical Celltrion Biocon Amgen Samsung Biologics Mylan Dr. Reddy's Laboratories Stada Arzneimittel AG This report segments the Global Follow-on Biologics Market as follows: Global Follow-on Biologics Market: Type Segment Analysis Recombinant Non-glycosylated Proteins Recombinant Glycosylated Proteins Recombinant Peptides Global Follow-on Biologics Market: Application Segment Analysis Oncology Blood Disorders Chronic Diseases Autoimmune Diseases Growth Hormone Deficiency Infectious Diseases Other Diseases There are 13 chapters to put on view for Follow-on Biologics Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Follow-on Biologics Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Follow-on Biologics Market Overview 1.1.1 Follow-on Biologics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Follow-on Biologics Market Size and Analysis by Regions (2014-2019) 1.2.1 North America Follow-on Biologics Market Status and Outlook 1.2.2 EU Follow-on Biologics Market Status and Outlook 1.2.3 Japan Follow-on Biologics Market Status and Outlook 1.2.4 China Follow-on Biologics Market Status and Outlook 1.2.5 India Follow-on Biologics Market Status and Outlook 1.2.6 Southeast Asia Follow-on Biologics Market Status and Outlook 1.3 Global Follow-on Biologics Market Segment by Types (2014-2025) 1.3.1 Global Follow-on Biologics Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global Follow-on Biologics Revenue Market Share by Types in 2018 1.3.3 Recombinant Non-glycosylated Proteins 1.3.4 Recombinant Glycosylated Proteins 1.3.5 Recombinant Peptides Others 1.4 Follow-on Biologics Market by End Users/Application 1.4.1 Global Follow-on Biologics Revenue (USD Mn) Comparison by Applications (2014-2025) 1.4.1 Oncology 1.4.2 Blood Disorders 1.4.3 Chronic Diseases Others Chapter 2 Global Follow-on Biologics Competition Analysis by Players 2.1 Global Follow-on Biologics Market Size (Million USD) by Players (2014-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Sandoz 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Sandoz, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.1.5 Recent Developments 3.2 Pfizer 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Pfizer, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.2.5 Recent Developments 3.3 Teva Pahrmaceutical 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Teva Pahrmaceutical, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.3.5 Recent Developments 3.4 Celltrion 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Celltrion, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.4.5 Recent Developments 3.5 Biocon 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Biocon, Follow-on Biologics Revenue (Million USD)(2014-2019) 3.5.5 Recent Developments 3.6 Amgen 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Amgen, Follow-on Biologics Revenue (Million USD)(2014-2019) 3.6.5 Recent Developments 3.7 Samsung Biologics 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Samsung Biologics, Follow-on Biologics Revenue (Million USD)(2014-2019) 3.7.5 Recent Developments 3.8 Mylan 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Mylan, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.8.5 Recent Developments 3.9 Dr. Reddy's Laboratories 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Dr. Reddy's Laboratories, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.9.5 Recent Developments 3.10 Stada Arzneimittel AG 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Stada Arzneimittel AG, Follow-on Biologics Revenue (Million USD) (2014-2019) 3.10.5 Recent Developments Chapter 4 Global Follow-on Biologics Market Size Type (2014-2019) 4.1 Global Follow-on Biologics Market Size by Type (2014-2019) Chapter 5 Global Follow-on Biologics Market Size Application (2014-2019) 5.1 Global Follow-on Biologics Market Size by Application (2014-2019) 5.2 Potential Application of Follow-on Biologics in Future 5.3 Top Consumer / End Users of Follow-on Biologics Chapter 6 North America Follow-on Biologics Development Status and Outlook 6.1 North America Follow-on Biologics Market Size (2014-2019) 6.2 North America Follow-on Biologics Market Size by Application (2014-2019) Chapter 7 EU Follow-on Biologics Development Status and Outlook 7.1 EU Follow-on Biologics Market Size (2014-2019) 7.2 EU Follow-on Biologics Market Size by Application (2014-2019) Chapter 8 Japan Follow-on Biologics Development Status and Outlook 8.1 Japan Follow-on Biologics Market Size (2014-2019) 8.2 Japan Follow-on Biologics Market Size by Application (2014-2019) Chapter 9 China Follow-on Biologics Development Status and Outlook 9.1 China Follow-on Biologics Market Size and Forecast (2014-2019) 9.2 China Follow-on Biologics Market Size by Application (2014-2019) Chapter 10 India Follow-on Biologics Development Status and Outlook 10.1 India Follow-on Biologics Market Size and Forecast (2014-2019) 10.2 India Follow-on Biologics Market Size by Application (2014-2019) Chapter 11 Southeast Asia Follow-on Biologics Development Status and Outlook 11.1 Southeast Asia Follow-on Biologics Market Size and Forecast (2014-2019) 11.2 Southeast Asia Follow-on Biologics Market Size by Application (2014-2019) Chapter 12 Market Forecast by Regions and Application (2019-2025) 12.1 Global Follow-on Biologics Market Size (Million USD) by Regions (2019-2025) 12.1. North America Follow-on Biologics Revenue and Growth Rate (2019-2025) 12.1.2 EU Follow-on Biologics Revenue and Growth Rate (2019-2025) 12.1.3 China Follow-on Biologics Revenue and Growth Rate (2019-2025) 12.1.4 Japan Follow-on Biologics Revenue and Growth Rate (2019-2025) 12.1.5 Southeast Asia Follow-on Biologics Revenue and Growth Rate (2019-2025) 12.1.6 India Follow-on Biologics Revenue and Growth Rate (2019-2025) 12.2 Global Follow-on Biologics Market Size by Application (2019-2025) Chapter 13 Follow-on Biologics Market Dynamics 13.1 Follow-on Biologics Market Opportunities 13.2 Follow-on Biologics Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Follow-on Biologics Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Follow-on Biologics Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
3129

6722

OUR CLIENT